Technical Analysis for HEPA - Hepion Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 3.58 5.60% 0.19
HEPA closed up 5.6 percent on Friday, November 22, 2019, on 1.27 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical HEPA trend table...

Date Alert Name Type % Chg
MACD Bullish Centerline Cross Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
Crossed Above 20 DMA Bullish 5.60%
Crossed Above 50 DMA Bullish 5.60%
New Uptrend Bullish 5.60%

Older signals for HEPA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of pleiotropic drug therapy for the treatment of chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that has completed the Phase I clinical trials for multiple biochemical pathways involved in the progression of liver diseases; and TXL, a lipid acyclic nucleoside phosphonate that delivers high intracellular concentrations of the active antiviral agent tenofovir diphosphate for the treatment of Hepatitis B. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.
Medicine Chemistry Biopharmaceutical Medical Specialties Hepatitis B Hepatotoxins Liver Diseases Drug Therapy Gilead Sciences Chronic Liver Diseases Purines Tenofovir Disoproxil Treatment Of Hepatitis B
Is HEPA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 39.2
52 Week Low 2.0001
Average Volume 1,517,766
200-Day Moving Average 7.6934
50-Day Moving Average 2.866
20-Day Moving Average 3.0145
10-Day Moving Average 2.884
Average True Range 0.4192
ADX 27.22
+DI 43.8618
-DI 16.7278
Chandelier Exit (Long, 3 ATRs ) 3.2924
Chandelier Exit (Short, 3 ATRs ) 3.6576
Upper Bollinger Band 3.6059
Lower Bollinger Band 2.4231
Percent B (%b) 0.98
BandWidth 39.237021
MACD Line 0.0186
MACD Signal Line -0.0052
MACD Histogram 0.0238
Fundamentals Value
Market Cap 279.26 Million
Num Shares 78 Million
EPS -0.30
Price-to-Earnings (P/E) Ratio -11.89
Price-to-Sales 0.00
Price-to-Book 5.28
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.30
Resistance 3 (R3) 4.25 3.97 4.18
Resistance 2 (R2) 3.97 3.78 3.99 4.14
Resistance 1 (R1) 3.77 3.67 3.87 3.82 4.10
Pivot Point 3.49 3.49 3.54 3.51 3.49
Support 1 (S1) 3.29 3.30 3.39 3.34 3.06
Support 2 (S2) 3.01 3.19 3.03 3.02
Support 3 (S3) 2.81 3.01 2.98
Support 4 (S4) 2.86